发明授权
US07858655B2 Drug preparation comprising α-lipoic acid, ambroxol and/or inhibitors of the angiotensin-converting enzyme (ACE) and its use for the treatment of neurodegenerative diseases
失效
包含α-硫辛酸，氨溴索和/或血管紧张素转化酶（ACE）抑制剂及其用于治疗神经变性疾病的药物制剂
- 专利标题： Drug preparation comprising α-lipoic acid, ambroxol and/or inhibitors of the angiotensin-converting enzyme (ACE) and its use for the treatment of neurodegenerative diseases
- 专利标题（中）： 包含α-硫辛酸，氨溴索和/或血管紧张素转化酶（ACE）抑制剂及其用于治疗神经变性疾病的药物制剂
-
申请号： US10764676申请日： 2004-01-26
-
公开(公告)号： US07858655B2公开(公告)日： 2010-12-28
- 发明人: Peter Röhnert , Frank Striggow , Klaus Reymann , Siegfried Ansorge , Michael Täger , Ulrich Schröder
- 申请人： Peter Röhnert , Frank Striggow , Klaus Reymann , Siegfried Ansorge , Michael Täger , Ulrich Schröder
- 申请人地址： DE Magdeburg
- 专利权人： Keyneurotek Pharmaceuticals AG
- 当前专利权人： Keyneurotek Pharmaceuticals AG
- 当前专利权人地址： DE Magdeburg
- 代理机构： Hodgson Russ LLP
- 主分类号： A61K31/40
- IPC分类号： A61K31/40
摘要：
The present invention concerns the use of Provided is a drug composition and a method for using the composition for the prevention and the therapy of neurodegenerative diseases. The combination comprises at least two of the following substances: α-lipoic acid; ambroxol and one or several inhibitor(s) of the angiotension-converting enzyme (ACE).